(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAP1B mRNA] CTD PMID:31150632 1,1-dichloroethene increases expression ISO Map1b (Mus musculus) 6480464 vinylidene chloride results in increased expression of MAP1B mRNA CTD PMID:26682919 1,2-dichloroethane affects expression ISO Map1b (Mus musculus) 6480464 ethylene dichloride affects the expression of MAP1B mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO Map1b (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MAP1B mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of MAP1B mRNA CTD PMID:30723492 17beta-estradiol increases expression ISO MAP1B (Homo sapiens) 6480464 Estradiol results in increased expression of MAP1B mRNA CTD PMID:20106945 and PMID:31614463 17beta-estradiol multiple interactions ISO MAP1B (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of MAP1B mRNA CTD PMID:30165855 17beta-estradiol decreases expression ISO MAP1B (Homo sapiens) 6480464 Estradiol results in decreased expression of MAP1B mRNA CTD PMID:19167446 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Map1b (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:21394737 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Map1b (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Map1b (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAP1B mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAP1B mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO MAP1B (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of MAP1B mRNA CTD PMID:21632981 and PMID:21802500 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Map1b (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of MAP1B mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MAP1B mRNA CTD PMID:22298810 and PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO MAP1B (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of MAP1B mRNA CTD PMID:20106945 2,5-hexanedione decreases expression EXP 6480464 2 more ... CTD PMID:20554699 and PMID:31760062 2-methylcholine affects expression ISO MAP1B (Homo sapiens) 6480464 beta-methylcholine affects the expression of MAP1B mRNA CTD PMID:21179406 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of MAP1B mRNA CTD PMID:30071829 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of MAP1B mRNA and alpha-Chlorohydrin results in increased expression of MAP1B protein CTD PMID:28522335 and PMID:34915118 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1 and 2-dithiol-3-thione results in increased expression of MAP1B mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of MAP1B mRNA CTD PMID:30723492 4,4'-sulfonyldiphenol decreases methylation ISO Map1b (Mus musculus) 6480464 bisphenol S results in decreased methylation of MAP1B exon CTD PMID:33297965 4,4'-sulfonyldiphenol affects methylation ISO Map1b (Mus musculus) 6480464 bisphenol S affects the methylation of MAP1B gene CTD PMID:31683443 4,4'-sulfonyldiphenol increases methylation ISO MAP1B (Homo sapiens) 6480464 bisphenol S results in increased methylation of MAP1B gene CTD PMID:31601247 4-hydroxyphenyl retinamide increases expression ISO Map1b (Mus musculus) 6480464 Fenretinide results in increased expression of MAP1B mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of MAP1B mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of MAP1B mRNA CTD PMID:31881176 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of MAP1B mRNA CTD PMID:23630614 and PMID:25378103 aflatoxin B1 decreases methylation ISO MAP1B (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of MAP1B gene CTD PMID:27153756 all-trans-retinoic acid decreases expression ISO MAP1B (Homo sapiens) 6480464 Tretinoin results in decreased expression of MAP1B mRNA CTD PMID:21934132 ammonium chloride decreases expression EXP 6480464 Ammonium Chloride results in decreased expression of MAP1B protein CTD PMID:16483693 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MAP1B mRNA CTD PMID:16483693 antimycin A decreases expression ISO MAP1B (Homo sapiens) 6480464 Antimycin A results in decreased expression of MAP1B mRNA CTD PMID:33512557 antirheumatic drug increases expression ISO MAP1B (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of MAP1B mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO MAP1B (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of MAP1B mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO MAP1B (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to MAP1B protein] CTD PMID:32406909 arsenous acid increases expression ISO MAP1B (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of MAP1B mRNA CTD PMID:20458559 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of MAP1B mRNA CTD PMID:36841081 azathioprine increases expression ISO MAP1B (Homo sapiens) 6480464 Azathioprine results in increased expression of MAP1B mRNA CTD PMID:22623647 azoxystrobin decreases expression ISO MAP1B (Homo sapiens) 6480464 azoxystrobin results in decreased expression of MAP1B mRNA CTD PMID:33512557 benzo[a]pyrene increases expression ISO Map1b (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of MAP1B mRNA CTD PMID:32417428 benzo[a]pyrene increases expression ISO MAP1B (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of MAP1B mRNA CTD PMID:35870112 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of MAP1B mRNA CTD PMID:16648578 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of MAP1B mRNA CTD PMID:20920545 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MAP1B mRNA CTD PMID:25181051 and PMID:30816183 bisphenol A increases expression ISO MAP1B (Homo sapiens) 6480464 bisphenol A analog results in increased expression of MAP1B mRNA and bisphenol A results in increased expression of MAP1B protein CTD PMID:32387340 and PMID:34186270 bisphenol A affects expression ISO MAP1B (Homo sapiens) 6480464 bisphenol A affects the expression of MAP1B mRNA CTD PMID:30903817 Bisphenol B increases expression ISO MAP1B (Homo sapiens) 6480464 bisphenol B results in increased expression of MAP1B protein CTD PMID:34186270 bisphenol F increases expression ISO MAP1B (Homo sapiens) 6480464 bisphenol F results in increased expression of MAP1B protein CTD PMID:34186270 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of MAP1B protein CTD PMID:28903499 butanal increases expression ISO MAP1B (Homo sapiens) 6480464 butyraldehyde results in increased expression of MAP1B mRNA CTD PMID:26079696 cadmium atom increases expression ISO MAP1B (Homo sapiens) 6480464 Cadmium results in increased expression of MAP1B mRNA CTD PMID:21120746 and PMID:23369406 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of MAP1B mRNA CTD PMID:33453195 caffeine affects phosphorylation ISO MAP1B (Homo sapiens) 6480464 Caffeine affects the phosphorylation of MAP1B protein CTD PMID:35688186 cannabidiol increases expression ISO MAP1B (Homo sapiens) 6480464 Cannabidiol results in increased expression of MAP1B mRNA CTD PMID:27714895 and PMID:27918106 carbon nanotube decreases expression ISO Map1b (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of MAP1B protein CTD PMID:33892499 CGP 52608 multiple interactions ISO MAP1B (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to MAP1B gene] CTD PMID:28238834 chlordecone multiple interactions ISO Map1b (Mus musculus) 6480464 Chlordecone promotes the reaction [Biomarkers metabolite binds to MAP1B gene] CTD PMID:31084621 clobetasol decreases expression ISO Map1b (Mus musculus) 6480464 Clobetasol results in decreased expression of MAP1B mRNA CTD PMID:27462272 clozapine decreases expression ISO MAP1B (Homo sapiens) 6480464 Clozapine results in decreased expression of MAP1B protein CTD PMID:34122009 cobalt dichloride increases expression ISO MAP1B (Homo sapiens) 6480464 cobaltous chloride results in increased expression of MAP1B mRNA CTD PMID:19376846 cocaine affects expression EXP 6480464 Cocaine affects the expression of MAP1B mRNA CTD PMID:20187946 cocaine decreases expression ISO MAP1B (Homo sapiens) 6480464 Cocaine results in decreased expression of MAP1B mRNA CTD PMID:12629581 copper atom multiple interactions ISO MAP1B (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of MAP1B mRNA CTD PMID:20971185 copper(0) multiple interactions ISO MAP1B (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of MAP1B mRNA CTD PMID:20971185 copper(II) sulfate increases expression ISO MAP1B (Homo sapiens) 6480464 Copper Sulfate results in increased expression of MAP1B mRNA CTD PMID:19549813 coumarin affects phosphorylation ISO MAP1B (Homo sapiens) 6480464 coumarin affects the phosphorylation of MAP1B protein CTD PMID:35688186 coumestrol decreases expression ISO MAP1B (Homo sapiens) 6480464 Coumestrol results in decreased expression of MAP1B mRNA CTD PMID:19167446 coumestrol multiple interactions ISO MAP1B (Homo sapiens) 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 CU-O LINKAGE affects phosphorylation ISO MAP1B (Homo sapiens) 6480464 cupric oxide affects the phosphorylation of MAP1B protein CTD PMID:25470785 cyclosporin A increases expression ISO MAP1B (Homo sapiens) 6480464 Cyclosporine results in increased expression of MAP1B mRNA CTD PMID:21632981 more ... daunorubicin affects response to substance ISO MAP1B (Homo sapiens) 6480464 MAP1B affects the susceptibility to Daunorubicin CTD PMID:17545624 deguelin decreases expression ISO MAP1B (Homo sapiens) 6480464 deguelin results in decreased expression of MAP1B mRNA CTD PMID:33512557 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of MAP1B mRNA CTD PMID:20032058 dexamethasone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of MAP1B mRNA] CTD PMID:20032058 diarsenic trioxide increases expression ISO MAP1B (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of MAP1B mRNA CTD PMID:20458559 diazinon decreases expression ISO Map1b (Mus musculus) 6480464 Diazinon results in decreased expression of MAP1B protein CTD PMID:17239417 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of MAP1B mRNA CTD PMID:21266533 diiodine decreases expression EXP 6480464 Iodine deficiency results in decreased expression of MAP1B protein CTD PMID:27444543 dimethylarsinic acid decreases expression EXP 6480464 Cacodylic Acid results in decreased expression of MAP1B mRNA CTD PMID:37567419 diuron decreases expression EXP 6480464 Diuron results in decreased expression of MAP1B mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO MAP1B (Homo sapiens) 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects expression ISO MAP1B (Homo sapiens) 6480464 Doxorubicin affects the expression of MAP1B protein CTD PMID:29385562 doxorubicin decreases expression ISO MAP1B (Homo sapiens) 6480464 Doxorubicin results in decreased expression of MAP1B mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of MAP1B mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO MAP1B (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAP1B mRNA CTD PMID:19167446 enzyme inhibitor multiple interactions ISO MAP1B (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MAP1B protein CTD PMID:23301498 ethanol increases expression EXP 6480464 Ethanol results in increased expression of MAP1B mRNA CTD PMID:17618662 ethanol affects splicing ISO Map1b (Mus musculus) 6480464 Ethanol affects the splicing of MAP1B mRNA CTD PMID:30319688 ethanol multiple interactions EXP 6480464 [Dronabinol co-treated with Ethanol] results in increased expression of MAP1B mRNA CTD PMID:17618662 fenpyroximate decreases expression ISO MAP1B (Homo sapiens) 6480464 fenpyroximate results in decreased expression of MAP1B mRNA CTD PMID:33512557 fipronil increases expression EXP 6480464 fipronil results in increased expression of MAP1B mRNA CTD PMID:31881178 fluoxetine increases expression EXP 6480464 Fluoxetine results in increased expression of MAP1B mRNA CTD PMID:17033635 folic acid affects expression ISO MAP1B (Homo sapiens) 6480464 Folic Acid affects the expression of MAP1B mRNA CTD PMID:17320366 folic acid increases expression ISO Map1b (Mus musculus) 6480464 Folic Acid results in increased expression of MAP1B mRNA CTD PMID:25629700 folic acid multiple interactions ISO Map1b (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MAP1B mRNA CTD PMID:22206623 FR900359 affects phosphorylation ISO MAP1B (Homo sapiens) 6480464 FR900359 affects the phosphorylation of MAP1B protein CTD PMID:37730182 geldanamycin increases expression ISO MAP1B (Homo sapiens) 6480464 geldanamycin results in increased expression of MAP1B mRNA CTD PMID:26705709 glyphosate increases methylation EXP 6480464 Glyphosate results in increased methylation of MAP1B gene CTD PMID:31011160 gold atom increases expression ISO MAP1B (Homo sapiens) 6480464 Gold results in increased expression of MAP1B mRNA CTD PMID:29705079 gold(0) increases expression ISO MAP1B (Homo sapiens) 6480464 Gold results in increased expression of MAP1B mRNA CTD PMID:29705079 hydrogen peroxide multiple interactions ISO Map1b (Mus musculus) 6480464 [Hydrogen Peroxide co-treated with N-(oxo-5 more ... CTD PMID:31494107 hydroquinone increases expression ISO MAP1B (Homo sapiens) 6480464 hydroquinone results in increased expression of MAP1B mRNA CTD PMID:31256213 ivermectin decreases expression ISO MAP1B (Homo sapiens) 6480464 Ivermectin results in decreased expression of MAP1B protein CTD PMID:32959892 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of MAP1B mRNA CTD PMID:20080153 leflunomide increases expression ISO MAP1B (Homo sapiens) 6480464 leflunomide results in increased expression of MAP1B mRNA CTD PMID:28988120 lipopolysaccharide increases expression ISO MAP1B (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of MAP1B mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO MAP1B (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 methylmercury chloride increases expression ISO MAP1B (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of MAP1B mRNA CTD PMID:23179753 and PMID:26272509 methylmercury chloride multiple interactions ISO MAP1B (Homo sapiens) 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP1B mRNA CTD PMID:27188386 methylseleninic acid affects expression ISO MAP1B (Homo sapiens) 6480464 methylselenic acid affects the expression of MAP1B mRNA CTD PMID:14617803 methylseleninic acid increases expression ISO MAP1B (Homo sapiens) 6480464 methylselenic acid results in increased expression of MAP1B mRNA CTD PMID:18548127 miconazole decreases expression ISO Map1b (Mus musculus) 6480464 Miconazole results in decreased expression of MAP1B mRNA CTD PMID:27462272 mifepristone increases expression ISO MAP1B (Homo sapiens) 6480464 Mifepristone results in increased expression of MAP1B mRNA CTD PMID:17584828 mono(2-ethylhexyl) phthalate increases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of MAP1B mRNA CTD PMID:16809437 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of MAP1B gene CTD PMID:33148267 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO Map1b (Mus musculus) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of MAP1B mRNA CTD PMID:25566086 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO Map1b (Mus musculus) 6480464 MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of MAP1B mRNA] CTD PMID:25566086 paracetamol increases expression ISO MAP1B (Homo sapiens) 6480464 Acetaminophen results in increased expression of MAP1B mRNA CTD PMID:21420995 and PMID:29067470 PCB138 multiple interactions ISO Map1b (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:21673325 perfluorooctanoic acid increases expression ISO MAP1B (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of MAP1B protein CTD PMID:26879310 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of MAP1B gene CTD PMID:33148267 phenylmercury acetate increases expression ISO MAP1B (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of MAP1B mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO MAP1B (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP1B mRNA CTD PMID:27188386 phenytoin increases expression ISO MAP1B (Homo sapiens) 6480464 Phenytoin results in increased expression of MAP1B mRNA CTD PMID:14741686 potassium chromate decreases expression ISO MAP1B (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of MAP1B mRNA CTD PMID:22714537 progesterone increases expression EXP 6480464 Progesterone results in increased expression of MAP1B mRNA CTD PMID:20726854 propanal increases expression ISO MAP1B (Homo sapiens) 6480464 propionaldehyde results in increased expression of MAP1B mRNA CTD PMID:26079696 pyrimidifen decreases expression ISO MAP1B (Homo sapiens) 6480464 pyrimidifen results in decreased expression of MAP1B mRNA CTD PMID:33512557 quercetin increases expression ISO MAP1B (Homo sapiens) 6480464 Quercetin results in increased expression of MAP1B mRNA CTD PMID:21632981 resveratrol multiple interactions ISO MAP1B (Homo sapiens) 6480464 [Coumestrol co-treated with Resveratrol] results in decreased expression of MAP1B mRNA and [Plant Extracts co-treated with Resveratrol] results in decreased expression of MAP1B mRNA CTD PMID:19167446 and PMID:23557933 resveratrol decreases expression ISO MAP1B (Homo sapiens) 6480464 resveratrol results in decreased expression of MAP1B mRNA CTD PMID:19167446 rotenone decreases expression ISO MAP1B (Homo sapiens) 6480464 Rotenone results in decreased expression of MAP1B mRNA CTD PMID:33512557 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO MAP1B (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 SB 431542 multiple interactions ISO MAP1B (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:37664457 silicon dioxide increases expression ISO MAP1B (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of MAP1B mRNA CTD PMID:25895662 sodium arsenate increases expression ISO Map1b (Mus musculus) 6480464 sodium arsenate results in increased expression of MAP1B mRNA CTD PMID:21795629 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of MAP1B protein CTD PMID:29459688 sodium arsenite decreases expression ISO MAP1B (Homo sapiens) 6480464 sodium arsenite results in decreased expression of MAP1B mRNA CTD PMID:34032870 sulforaphane decreases expression ISO MAP1B (Homo sapiens) 6480464 sulforaphane results in decreased expression of MAP1B mRNA CTD PMID:31838189 sunitinib increases expression ISO MAP1B (Homo sapiens) 6480464 Sunitinib results in increased expression of MAP1B mRNA CTD PMID:31533062 T-2 toxin decreases expression ISO MAP1B (Homo sapiens) 6480464 T-2 Toxin results in decreased expression of MAP1B mRNA CTD PMID:34581912 tebufenpyrad decreases expression ISO MAP1B (Homo sapiens) 6480464 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of MAP1B mRNA CTD PMID:33512557 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of MAP1B mRNA] CTD PMID:20032058 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAP1B mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of MAP1B mRNA CTD PMID:31150632 tetrahydropalmatine increases expression ISO MAP1B (Homo sapiens) 6480464 tetrahydropalmatine results in increased expression of MAP1B protein CTD PMID:20109541 thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of MAP1B protein CTD PMID:35544339 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of MAP1B mRNA CTD PMID:23411599 and PMID:34492290 trichloroethene decreases phosphorylation ISO MAP1B (Homo sapiens) 6480464 Trichloroethylene results in decreased phosphorylation of MAP1B protein CTD PMID:26018768 valproic acid increases expression ISO MAP1B (Homo sapiens) 6480464 Valproic Acid results in increased expression of MAP1B mRNA CTD PMID:23179753 more ... valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of MAP1B mRNA CTD PMID:29427782 valproic acid affects expression ISO MAP1B (Homo sapiens) 6480464 Valproic Acid affects the expression of MAP1B mRNA CTD PMID:25979313 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of MAP1B mRNA CTD PMID:19015723 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of MAP1B mRNA CTD PMID:23034163 vorinostat decreases expression ISO MAP1B (Homo sapiens) 6480464 vorinostat results in decreased expression of MAP1B mRNA CTD PMID:27188386 xylitol increases expression ISO MAP1B (Homo sapiens) 6480464 Xylitol results in increased expression of MAP1B mRNA CTD PMID:32275922